Cinemark Holdings Inc. (NYSE:CNK): According to JPMorgan, recent pullbacks in Cinemark (NYSE:CNK) and Regal Entertainment (NYSE:RGC) are overdone ahead of a strong movie slate anticipated for the second half of 2012. The firm reiterates Overweight ratings on both stocks.
Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): Leerink thinks that added earnings potential from the acquisition of EUSA Pharma which was completed recently does not show in the stock. The firm views this as an opportunity for investors. The firm maintains its Outperform rating and $68 price target on the shares.
Investing Insights: Early Buzzers: P&G Cuts Guidance, Arena Pharma Jumps 3% and Adobe CRASHES 6%.
Constant Contact, Inc. (NASDAQ:CTCT) stock has most likely bottomed, according to Oppenheimer. The firm believes the company’s revenue growth will pick up and its margins with rise in 2013.
THQ Inc. (NASDAQ:THQI): If able to execute on its limited release line-up, Brean Murray believes that THQ Inc. might achieve its revenue guidance for 2013. If it is executed, it will provide sufficient cash needed to support an expanded lineup in 2014. Also according to the firm, THQ Inc. continues making progress on its turnaround and intends to implement a reverse stock split as a way to maintain its exchange listing. The firm gives a Hold rating to the shares.
Jabil Circuit Inc. (NYSE:JBL): Following the company’s reported in-line results and provided guidance for August which were lower than expectations, RBC Capital decreased its target for Jablil, but the firm sees the company exceeding expectations for its averages seasonality during its November quarter and beyond. The firm reiterates its Outperform rating on the stock.
Don’t Miss: Who’s CONQUERING the Online Video Space?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.